The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Pravastatin Mylan 20 mg Tablets

20 milligram(s) Tablet

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/136/002

Main Information

Trade NamePravastatin Mylan 20 mg Tablets
Active SubstancesPravastatin sodium
Strength20 milligram(s)
Dosage FormTablet
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/136/002

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA03 pravastatin


Licence Issued17/12/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0014-003-014
Interchangeable List DocumentPDF of Interchangeable List
« Back